Unprecedented access to more than 55,000 global decision-makers in precision medicine
Clinical OMICs readers are driven by a need for the latest news, features, and analysis on molecular diagnostics in precision medicine. They are active, motivated, and hungry, consistently consuming information across multiple channels throughout the day as evidenced by our insightful data and the deep, constructive reader feedback provided in our commissioned Signet AdBrand studies.
- Hospital/Medical Center/Clinical Lab36.6%
- Pharmaceutical/Biopharma/Biotech Company18.5%
- Diagnostic Manufacturer/Life Science Tools11.3%
- Clinical Researcher/Research Scientist/R&D26.7%
- Lab Director/Manager/Administrator24.8%
- Executives/Senior Management12.0%